Literature DB >> 1533520

Fibrinolytic and anticoagulant activities of highly sulfated fucoidan.

S Soeda1, S Sakaguchi, H Shimeno, A Nagamatsu.   

Abstract

A series of fucoidan [sulfated poly(L-fucopyranose)] derivatives were prepared by chemical sulfation and desulfation, and they were tested for their abilities to stimulate tissue plasminogen activator (t-PA)-catalyzed plasminogen activation, clot lysis, and the inhibition of fibrin polymer formation. The magnitude of their activities was dependent upon the degree of sulfation. A striking feature of the sulfated fucoidan was that, unlike heparin, it stimulated t-PA-induced plasma clot lysis by protecting plasmin activity from alpha 2-plasmin inhibitor and decreased the rate of fibrin polymer formation. The inhibition of hyaluronic acid-mediated enhancement of fibrin clot formation was also observed with the fucoidan derivative. We also showed that highly sulfated fucoidan prevents significantly endotoxin-induced hepatic vein thrombosis in the hyperlipemic rat model. The present results are the first to describe the fibrinolytic and anticoagulant activities of fucoidan, and thus may provide useful clues for the development of an ideal thrombolytic agent.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533520     DOI: 10.1016/0006-2952(92)90721-t

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  The in vitro and in vivo effects of the low molecular weight fucoidan on the bone osteogenic differentiation properties.

Authors:  Pai-An Hwang; Yu-Lan Hung; Nam Nhut Phan; Bui-Thi-Ngoc Hieu; Po-Ming Chang; Kuan-Lun Li; Yen-Chang Lin
Journal:  Cytotechnology       Date:  2015-08-14       Impact factor: 2.058

2.  Mechanism of the stimulatory effect of native fucoidan, highly sulfated fucoidan and heparin on plasminogen activation by tissue plasminogen activator: the role of chloride.

Authors:  DeShawn Lang; Talya Williams; Altovise Phillips; V M Doctor
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Oct-Dec       Impact factor: 2.441

3.  Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator.

Authors:  E Muneer; J Bell; V M Doctor
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Apr-Jun       Impact factor: 2.569

4.  Relationship between oversulfation and conformation of low and high molecular weight fucoidans and evaluation of their in vitro anticancer activity.

Authors:  Myoung Lae Cho; Boo-Yong Lee; Sang Guan You
Journal:  Molecules       Date:  2010-12-30       Impact factor: 4.411

5.  PM2.5 induced cardiac hypertrophy via CREB/GSK3b/SOS1 pathway and metabolomics alterations.

Authors:  Kuan-Lun Li; Yen-Chang Lin
Journal:  Oncotarget       Date:  2018-07-20

6.  Effect of Oversulfation on the Composition, Structure, and In Vitro Anti-Lung Cancer Activity of Fucoidans Extracted from Sargassum aquifolium.

Authors:  Hui-Hua Hsiao; Tien-Chiu Wu; Yung-Hsiang Tsai; Chia-Hung Kuo; Ren-Han Huang; Yong-Han Hong; Chun-Yung Huang
Journal:  Mar Drugs       Date:  2021-04-12       Impact factor: 5.118

7.  Toxicological Evaluation of Low Molecular Weight Fucoidan in Vitro and in Vivo.

Authors:  Pai-An Hwang; Ming-De Yan; Hong-Ting Victor Lin; Kuan-Lun Li; Yen-Chang Lin
Journal:  Mar Drugs       Date:  2016-06-24       Impact factor: 5.118

8.  Inhibitory effect of oversulfated fucoidan on invasion through reconstituted basement membrane by murine Lewis lung carcinoma.

Authors:  S Soeda; S Ishida; H Shimeno; A Nagamatsu
Journal:  Jpn J Cancer Res       Date:  1994-11

9.  The Antithrombotic Effects of Low Molecular Weight Fragment from Enzymatically Modified of Laminaria Japonica Polysaccharide.

Authors:  Zhigang Xu; Zheng-Qin Zuo; Baibujiafu Gaowa; Yuan-Yun Gu; Chen Hui; Yong-Le Shen; Hou-Ping Xu
Journal:  Med Sci Monit       Date:  2020-04-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.